| 產(chǎn)品名稱(chēng) |
Nocardia nova Tsukamura |
| 商品貨號(hào) |
B244463 |
| Deposited As |
Nocardia asteroides (Eppinger) Blanchard |
| Strain Designations |
9974 [R.E. Gordon 401] |
| Isolation |
Human |
| Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format |
freeze-dried |
| Storage Conditions |
Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section |
| Preceptrol® |
no |
| Type Strain |
no |
| Comments |
Taxonomy Antibiotic susceptibility pattern |
| Medium |
ATCC® Medium 1877: ISP Medium 1
ATCC® Medium 196: Yeast malt extract agar
|
| Growth Conditions |
Temperature: 26°C
Atmosphere: Aerobic |
| Name of Depositor |
CW Emmons |
| Chain of Custody |
ATCC <-- CW Emmons <-- R. Lee |
| References |
Gordon RE, Mihm JM. A comparative study of some strains received as nocardiae. J. Bacteriol. 73: 15-27, 1957. PubMed: 13405855
Wallace RJ Jr., et al. Clinical and laboratory features of Nocardia nova. J. Clin. Microbiol. 29: 2407-2411, 1991. PubMed: 1774244
|
